Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Function and application of caspase activation and recruitment binding domain 3 (card3) gene in coronary atherosclerotic heart disease

A technology of coronary atherosclerosis and binding domains, applied in gene therapy, cardiovascular system diseases, medical preparations containing active ingredients, etc., can solve problems such as death, arrhythmia, and cardiac insufficiency

Active Publication Date: 2017-01-11
武汉惠康基因科技有限公司
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After myocardial infarction, only a small number of myocardial cells divide and proliferate, unable to effectively and completely repair myocardial tissue. Therefore, the myocardium in the infarcted area can only be replaced by scar tissue without contractile function through fibrous tissue hyperplasia, thereby causing severe arrhythmia, Heart failure or even death

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Function and application of caspase activation and recruitment binding domain 3 (card3) gene in coronary atherosclerotic heart disease
  • Function and application of caspase activation and recruitment binding domain 3 (card3) gene in coronary atherosclerotic heart disease
  • Function and application of caspase activation and recruitment binding domain 3 (card3) gene in coronary atherosclerotic heart disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] [Example 1] Myocardial infarction (MI) model acquisition

[0034] 1. Grouping of experimental animals: male C57BL / 6 background WT mice, Card3 knockout mice (Card3-KO), heart-specific Card3 transgenic mice (Card3-TG) and non-transgenic mice (NTG), by ligation A mouse model of myocardial infarction (MI) caused by the left anterior descending coronary artery (LAD). Randomly divided into 8 groups, each group: C57BL / 6 background WT mice sham operation group (WT Sham) and MI operation group (WT MI), Card3 gene knockout mouse sham operation group (Card3-KO Sham) and MI operation group group (Card3-KO MI), non-transgenic mouse sham operation group (NTG Sham) and MI operation group (NTG MI), heart-specific Card3 transgenic mouse sham operation group (Card3-TG Sham) and MI operation group (Card3 -TG MI).

[0035] 2. The MI model uses blocking the left anterior descending coronary artery (LAD) of the mouse heart to cause myocardial infarction. The operation process of the model ...

Embodiment 2

[0044] [Example 2] Detection of myocardial infarction ratio, myocardial hypertrophy and fibrosis in mouse myocardial infarction (MI) model

[0045] 1. Collect materials

[0046] (1) Preliminary work: prepare a urine cup filled with 20mL of 10% formaldehyde in advance, and label it (mouse number, group, type of operation and date of collection). Place the petri dish filled with 10% KCl solution at the sampling site. Turn on the analytical balance, adjust to zero, and then weigh and kill the mice.

[0047] (2) Material collection: Ophthalmic curved forceps clamped the vascular pedicle below the atrial appendage, cut off the heart, and quickly placed it in 10% KCl solution. After the heart stops beating in the diastolic phase, place it on sterilized gauze, gently squeeze the fluid in the heart cavity, dip the surface fluid dry, weigh and record, put the heart into the corresponding urine cup, fix it for 48 hours and use it for pathological testing.

[0048] (3) Relevant measu...

Embodiment 3

[0067] [Example 3] Detection of cardiac function in myocardial infarction (MI) model mice

[0068] 1 Ultrasound detection of cardiac function

[0069] 1.1 Early preparations

[0070] (1) Anesthesia machine preparation: first connect the oxygen cylinder and the air inlet port on the anesthesia machine, then unscrew the sealing cap of the dosing port on the anesthesia machine, quickly add isoflurane to the safety scale, and then tighten the sealing cap. Unscrew the main valve on the oxygen cylinder, adjust the knob of the flow control valve, and maintain the outlet pressure at 0.2-0.3mPa.

[0071] (2) Preparation of the mice to be tested: After the mice to be tested were quickly anesthetized with isoflurane, the hair on the left chest area was shaved, and the head of the treated mice was inserted into the anesthetic catheter sleeve, and treated with 1.5-2.0% isoflurane Alkane maintains a stable anesthesia in mice.

[0072] 1.2 Cardiac function test

[0073] The mice were pla...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses function and application of a Caspase activation and recruitment domain 3 (Card3) gene in a coronary atherosclerotic heart disease. The Card3 gene knockout mice and heart specific Card3 transgenic mice are taken as objects, and a research is carried out on a myocardial infarction model caused by blocking mice heart ramus descendens anterior arteriae coronariae sinistrae. The result proves that compared with WT mice, the cardiac infarction proportion, and the degrees of myocardial hypertrophy and fibrosis of the Card3 gene knockout mice are obviously inhibited, and the cardiac function is obviously improved; the phenotype of the Card3 transgenic mice is contrary to that of the Card3 gene knockout mice. Consequently, the Card3 gene can promote and increase development and progression of the coronary atherosclerotic heart disease, the Card3 can be used as a drug target for screening the drugs for treating the coronary atherosclerotic heart disease, and the inhibitor of the Card3 can be applied to preparation of a drug for treating the coronary atherosclerotic heart disease.

Description

technical field [0001] The invention belongs to the field of gene function and application, in particular to the function and application of a Caspase activation and recruitment binding domain 3 (Card3) gene in coronary atherosclerotic heart disease. Background technique [0002] Cardiovascular disease is the disease that causes the highest death rate in the world and is the number one killer of human health. Ischemic heart disease is the leading cause of death from cardiovascular diseases. Myocardial infarction (MI) is a common type of ischemic heart disease. If the blood supply of the myocardium is blocked for more than 30 minutes, various organelles will be ultrafine. Structural changes and dysfunction lead to irreversible damage and even death of cardiomyocytes. Within a few minutes after the onset of acute myocardial infarction, the myocardial cells in the ischemic central area will die due to ischemia, which is one of the common diseases that seriously threaten human ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K45/00A61K48/00A61P9/10
Inventor 李红良蒋丁胜刘小熊万埝
Owner 武汉惠康基因科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products